Dr. K speaks with Alzheimer’s expert Jason Karlawish, MD, about the new anti-amyloid Alzheimer’s medications lecanemab (Leqembi) and donanemab (Kisunla). They discuss how biomarkers have changed diagnosing Alzheimer’s disease, how well these new drugs work, and much more.
Отзывы